HealthDay News — Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight ...
Adults with moderately to severely active Crohn disease can now self-administer risankizumab induction at home using an ...
HealthDay News — Medical device adverse event reports are frequently incomplete, inaccurate, and delayed, according to a study published online October 14 in The BMJ.
The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...
The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...
Patients with baseline viral suppression maintained viral suppression, while those without achieved viral suppression by 13 ...
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...
The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...
Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.
Credit: Alcon The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged ...
Accelerated approval is supported by 34-week interim data from the phase 3 I CAN trial showing a statistically significant 43% placebo-adjusted reduction in proteinuria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results